China Resources Double-Crane Pharmaceutical Co., Ltd. approved the election of Zhang Kejian as Independent Director, at the 1st special shareholders' meeting held on February 19, 2016.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.33 CNY | -2.07% |
|
-2.96% | +9.30% |
14/06 | CR Double-Crane Pharmaceutical Gets Certificate to Market Low-Calcium Dialysis Solution | MT |
27/05 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.30% | 292.06Cr | |
+51.99% | 80TCr | |
-5.72% | 35TCr | |
+18.94% | 32TCr | |
+11.07% | 30TCr | |
+16.96% | 24TCr | |
+2.25% | 23TCr | |
+11.15% | 22TCr | |
+7.59% | 16TCr | |
-3.65% | 16TCr |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd. Approves the Election of Zhang Kejian as Independent Director